Wells Fargo
INO icon

Wells Fargo’s Inovio Pharmaceuticals INO Stock Holding History

Wells Fargo’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-83
Closed -$5K – 6584
2020
Q2 		$5K Buy
+83
New +$13.3K ﹤0.01% 5971

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wells Fargo's INO Position: Q2 2026 in Review

Wells Fargo increased its Inovio Pharmaceuticals (INO) stake by 14% in Q2 2026, buying an estimated $464 and bringing the position to 3,260 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #6284.

Wells Fargo first reported a position in INO in Q1 2014 and has held it in 50 quarters since. The position peaked at $11.1M in Q2 2020. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Wells Fargo held 3,260 shares of Inovio Pharmaceuticals worth $3.59K as of Q2 2026.
  • Wells Fargo bought 391 Inovio Pharmaceuticals shares in Q2 2026, an estimated $464.
  • Inovio Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6284 holding.
  • Wells Fargo first reported a position in Inovio Pharmaceuticals in Q1 2014 and has held it in 50 quarters since.
  • Wells Fargo's Inovio Pharmaceuticals position peaked at $11.1M in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.